Xylem Free Cash Flow (FCF) History (XYL)
Xylem reported $910.0M in free cash flow for fiscal 2025, a decrease of 3.40% from the previous fiscal year, with a free cash flow margin of 10.07%.
View full Xylem company overviewXylem free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $910.0M | −$32.0M | −3.40% | +10.07% |
| 2024 | 2024-12-31 | $942.0M | $376.0M | +66.43% | +11.00% |
| 2023 | 2023-12-31 | $566.0M | $178.0M | +45.88% | +7.69% |
| 2022 | 2022-12-31 | $388.0M | $58.0M | +17.58% | +7.03% |
| 2021 | 2021-12-31 | $330.0M | −$311.0M | −48.52% | +6.35% |
| 2020 | 2020-12-31 | $641.0M | $28.0M | +4.57% | +13.69% |
| 2019 | 2019-12-31 | $613.0M | $264.0M | +75.64% | +12.26% |
| 2018 | 2018-12-31 | $349.0M | −$167.0M | −32.36% | +7.03% |
| 2017 | 2017-12-31 | $516.0M | $143.0M | +38.34% | +10.96% |
| 2016 | 2016-12-31 | $373.0M | $26.0M | +7.49% | +9.89% |
| 2015 | 2015-12-31 | $347.0M | $50.0M | +16.84% | +9.50% |
| 2014 | 2014-12-31 | $297.0M | $99.0M | +50.00% | +7.58% |
| 2013 | 2013-12-31 | $198.0M | −$86.0M | −30.28% | +5.16% |
| 2012 | 2012-12-31 | $284.0M | −$39.0M | −12.07% | +7.49% |
| 2011 | 2011-12-31 | $323.0M | $22.0M | +7.31% | +8.49% |
| 2010 | 2010-12-31 | $301.0M | −$7.0M | −2.27% | +9.40% |
| 2009 | 2009-12-31 | $308.0M | — | — | +10.81% |
Xylem quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $201.0M | −$6.0M | −2.90% | +8.60% |
| Q1 2026 | 2026-03-31 | $18.0M | $56.0M | — | +0.85% |
| Q4 2025 | 2025-12-31 | $460.0M | −$15.0M | −3.16% | +19.19% |
| Q3 2025 | 2025-09-30 | $281.0M | $44.0M | +18.57% | +12.39% |
| Q2 2025 | 2025-06-30 | $207.0M | −$8.0M | −3.72% | +9.00% |
| Q1 2025 | 2025-03-31 | −$38.0M | −$53.0M | — | −1.84% |
| Q4 2024 | 2024-12-31 | $475.0M | $115.0M | +31.94% | +21.05% |
| Q3 2024 | 2024-09-30 | $237.0M | −$62.0M | −20.74% | +11.26% |
| Q2 2024 | 2024-06-30 | $215.0M | $240.0M | — | +9.91% |
| Q1 2024 | 2024-03-31 | $15.0M | $83.0M | — | +0.74% |
| Q4 2023 | 2023-12-31 | $360.0M | $58.0M | +19.21% | +17.00% |
| Q3 2023 | 2023-09-30 | $299.0M | $150.0M | +100.67% | +14.40% |
| Q2 2023 | 2023-06-30 | −$25.0M | −$92.0M | — | −1.45% |
| Q1 2023 | 2023-03-31 | −$68.0M | $62.0M | — | −4.70% |
| Q4 2022 | 2022-12-31 | $302.0M | $163.0M | +117.27% | +18.78% |
| Q3 2022 | 2022-09-30 | $149.0M | $84.0M | +129.23% | +10.80% |
| Q2 2022 | 2022-06-30 | $67.0M | −$124.0M | −64.92% | +5.11% |
| Q1 2022 | 2022-03-31 | −$130.0M | −$65.0M | — | −10.64% |
| Q4 2021 | 2021-12-31 | $139.0M | −$184.0M | −56.97% | +9.47% |
| Q3 2021 | 2021-09-30 | $65.0M | −$169.0M | −72.22% | +5.35% |
| Q2 2021 | 2021-06-30 | $191.0M | $54.0M | +39.42% | +14.67% |
| Q1 2021 | 2021-03-31 | −$65.0M | −$12.0M | — | −5.37% |
| Q4 2020 | 2020-12-31 | $323.0M | −$14.0M | −4.15% | +24.41% |
| Q3 2020 | 2020-09-30 | $234.0M | $35.0M | +17.59% | +20.00% |
| Q2 2020 | 2020-06-30 | $137.0M | $74.0M | +117.46% | +12.30% |
| Q1 2020 | 2020-03-31 | −$53.0M | −$67.0M | — | −4.93% |
| Q4 2019 | 2019-12-31 | $337.0M | $205.0M | +155.30% | +25.69% |
| Q3 2019 | 2019-09-30 | $199.0M | $72.0M | +56.69% | +16.17% |
| Q2 2019 | 2019-06-30 | $63.0M | −$25.0M | −28.41% | +4.92% |
| Q1 2019 | 2019-03-31 | $14.0M | $12.0M | +600.00% | +1.19% |
| Q4 2018 | 2018-12-31 | $132.0M | −$124.0M | −48.44% | +9.99% |
| Q3 2018 | 2018-09-30 | $127.0M | −$59.0M | −31.72% | +10.39% |
| Q2 2018 | 2018-06-30 | $88.0M | $23.0M | +35.38% | +7.00% |
| Q1 2018 | 2018-03-31 | $2.0M | −$7.0M | −77.78% | +0.17% |
| Q4 2017 | 2017-12-31 | $256.0M | $68.0M | +36.17% | +20.05% |
| Q3 2017 | 2017-09-30 | $186.0M | $65.0M | +53.72% | +15.56% |
| Q2 2017 | 2017-06-30 | $65.0M | $5.0M | +8.33% | +5.58% |
| Q1 2017 | 2017-03-31 | $9.0M | $5.0M | +125.00% | +0.84% |
| Q4 2016 | 2016-12-31 | $188.0M | $23.0M | +13.94% | +17.17% |
| Q3 2016 | 2016-09-30 | $121.0M | $5.0M | +4.31% | +13.49% |
| Q2 2016 | 2016-06-30 | $60.0M | −$4.0M | −6.25% | +6.44% |
| Q1 2016 | 2016-03-31 | $4.0M | $2.0M | +100.00% | +0.47% |
| Q4 2015 | 2015-12-31 | $165.0M | $44.0M | +36.36% | +16.60% |
| Q3 2015 | 2015-09-30 | $116.0M | −$10.0M | −7.94% | +12.86% |
| Q2 2015 | 2015-06-30 | $64.0M | $11.0M | +20.75% | +6.96% |
| Q1 2015 | 2015-03-31 | $2.0M | $5.0M | — | +0.24% |
| Q4 2014 | 2014-12-31 | $121.0M | −$5.0M | −3.97% | +11.61% |
| Q3 2014 | 2014-09-30 | $126.0M | $55.0M | +77.46% | +13.08% |
| Q2 2014 | 2014-06-30 | $53.0M | $42.0M | +381.82% | +5.27% |
| Q1 2014 | 2014-03-31 | −$3.0M | $7.0M | — | −0.33% |
| Q4 2013 | 2013-12-31 | $126.0M | −$9.0M | −6.67% | +12.20% |
| Q3 2013 | 2013-09-30 | $71.0M | −$10.0M | −12.35% | +7.36% |
| Q2 2013 | 2013-06-30 | $11.0M | −$27.0M | −71.05% | +1.15% |
| Q1 2013 | 2013-03-31 | −$10.0M | −$40.0M | — | −1.14% |
| Q4 2012 | 2012-12-31 | $135.0M | −$15.0M | −10.00% | +13.93% |
| Q3 2012 | 2012-09-30 | $81.0M | $16.0M | +24.62% | +8.70% |
| Q2 2012 | 2012-06-30 | $38.0M | −$18.0M | −32.14% | +3.93% |
| Q1 2012 | 2012-03-31 | $30.0M | −$22.0M | −42.31% | +3.24% |
| Q4 2011 | 2011-12-31 | $150.0M | — | — | +14.96% |
| Q3 2011 | 2011-09-30 | $65.0M | — | — | +6.92% |
| Q2 2011 | 2011-06-30 | $56.0M | — | — | +5.77% |
| Q1 2011 | 2011-03-31 | $52.0M | — | — | +5.84% |
Xylem free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from $641.0M to $910.0M, a compound annual growth rate of 7.26%. Xylem's latest reported quarter, Q2 2026, generated $201.0M in free cash flow, a decrease of 2.90% year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Xylem filings at SEC.gov ↗